mint-rasagiline tablet
mint pharmaceuticals inc - rasagiline (rasagiline mesylate) - tablet - 1mg - rasagiline (rasagiline mesylate) 1mg
jamp rasagiline tablet
jamp pharma corporation - rasagiline (rasagiline mesylate) - tablet - 0.5mg - rasagiline (rasagiline mesylate) 0.5mg - monoamine oxidase b inhibitors
rasagiline apotex
apotex europe b.v. - rasagiline mesilate - tablets - 1 milligram - rasagiline
asn-rasagiline tablet
ascend laboratories ltd - rasagiline (rasagiline mesylate) - tablet - 0.5mg - rasagiline (rasagiline mesylate) 0.5mg - monoamine oxidase b inhibitors
asn-rasagiline tablet
ascend laboratories ltd - rasagiline (rasagiline mesylate) - tablet - 1mg - rasagiline (rasagiline mesylate) 1mg - monoamine oxidase b inhibitors
jamp rasagiline tablet
jamp pharma corporation - rasagiline (rasagiline mesylate) - tablet - 1mg - rasagiline (rasagiline mesylate) 1mg - monoamine oxidase b inhibitors
rasagiline krka 1 mg tabl.
krka d.d. novo mesto d.d. - rasagiline mesylate 1,44 mg - eq. rasagiline 1 mg - tablet - 1 mg - rasagiline mesilate 1.44 mg - rasagiline
rasagiline teva 1 mg tabl.
teva pharma belgium sa-nv - rasagiline mesylate 1,56 mg - eq. rasagiline 1 mg - tablet - 1 mg - rasagiline mesilate 1.56 mg - rasagiline
rasagiline accord
accord healthcare limited - rasagiline tartrate - tablets - 1 milligram - rasagiline - anti-parkinson-drugs, monoamine oxidase -b inhibitors - rasagiline accord is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
rasagiline sandoz 1 mg
novartis israel ltd - rasagiline as tartrate - tablets - rasagiline as tartrate 1 mg - rasagiline - rasagiline sandoz® 1mg is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.